Liver Biology: Fundamental Mechanisms and Translational Applications

January 22, 2016

Bethesda, MD - The conference will cover all aspects of hepatocyte, cholangiocyte, hepatic stellate cell, sinusoidal endothelial cell and immune cell function in the healthy and diseased liver, their crosstalk and role in maintaining liver function and metabolism in normal and disease states, as well as mechanisms that regulate the identity and fate during development and adulthood.

With recent advances in the cure of hepatitis C hepatitis and the continuing obesity epidemic, the landscape of liver disease is changing. For this reason, one area the 2016 Liver Biology conference will focus on is metabolism and non-alcoholic fatty liver disease. This topic will receive broad coverage with a wide range of experts discussing basic mechanisms of hepatic metabolism, pathways regulating the progression of non-alcoholic steatohepatitis as well as the gut-liver axis. Additional focus of the conference will be on other key areas that require better understanding of the underlying biology in order to develop efficient therapeutic approaches. Foremost, this will include hepatocellular carcinoma, which remains a leading cause of death in patients with advanced liver disease. Tumor biology, signaling pathways and novel targets as well as the hepatic tumor microenvironment will be discussed in specific sessions. Although a number of underlying liver diseases can be cured, fibrosis can persist and cause severe clinical complications. Understanding mechanisms of fibrogenesis and targets will provide the basis for future treatments and be an integral part of the conference. Likewise, alcoholic liver disease remains a significant global problem and recent advances on mechanisms of alcohol-induced liver disease will be covered by leading experts in the field. Finally, the concept of the liver stem cell continues to receive heightened attention due to its potential relevance for therapeutic applications. The conference will present recent developments on the role of hepatocytes versus dedicated stem cells in regeneration of the liver.

A key focus of this conference is to encourage scientific exchange and discussions between attendees with dedicated time slots for discussions and several "meet-the-expert" workshops. The conference seeks to promote the participation of students, post-doctoral fellows and junior investigators. Short talks and travel awards will be provided to them if they are the designated presenter of the top 10-20% of submitted abstracts. Finally, daily poster sessions and social activities will allow plenty of opportunities for exchange of ideas and establishing collaboration amongst participants. This FASEB Liver Biology conference promises to be the best international basic liver meeting of its kind.

FASEB has announced a total of 36 Science Research Conferences (SRC) in 2016. Registration opens January 7, 2016. For more information about an SRC, view preliminary programs, or find a listing of all our 2016 SRCs, please visit
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes. In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at Proposal guidelines can be found at

FASEB is composed of 30 societies with more than 125,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

Federation of American Societies for Experimental Biology

Related Hepatitis Articles from Brightsurf:

Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint.

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma.

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum M√ľnchen, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.

Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum M√ľnchen and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Read More: Hepatitis News and Hepatitis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to